Business Daily from THE HINDU group of publications
Friday, Apr 11, 2008
ePaper | Mobile/PDA Version


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Overseas Investments
Orchid sets up subsidiary in Japan

Chennai, April 10

Orchid Chemicals & Pharmaceuticals Ltd on Thursday announced the formation of its whollyowned subsidiary in Japan called Orchid Pharma Japan K K (Orchid Japan). Orchid Japan, headquartered in Tokyo, will drive Orchid's foray into the high potential and growing Japanese generics market. "Orchid considers that the Japanese generics market will grow at a rapid pace in the coming years due to an increasing recognition in the government and healthcare sectors of the need for quality generic medicines," says a press release from Orchid. The company estimates that the generics market in Japan currently estimated at $2.5 billion could double itself in a span of 5 years. - Our Bureau

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Vijai Mantri to head DLF jt venture


Ball in Orchid’s court
Atlas Copco acquires 25% stake in 2 drilling tech firms
IMFA Group setting up power plant at Orissa facility
Cement firms add 17 mt capacity in fiscal 2008
Jotun’s paints plant to begin commercial production
SEL board okays new facility
Reliance Big acquires digital images biz of DTS Inc
Orchid sets up subsidiary in Japan
Glenmark to seek FDA clearance for trials
SPS Group to invest in food processing sector in Bengal
Mercedes-Benz India Q1 sales grow 59%


BusinessLine E-paper



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line